» Articles » PMID: 21991563

Mucosal Eosinophilia and Recurrence of Nasal Polyps - New Classification of Chronic Rhinosinusitis

Overview
Journal Rhinology
Date 2011 Oct 13
PMID 21991563
Citations 73
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Eosinophils and nasal polyps are believed to affect the surgical outcome of chronic rhinosinusitis (CRS). CRS is classified based on the presence of nasal polyps in western countries. The majority of patients with CRS with nasal polyps (CRS with NP) are characterized by predominantly eosinophilic inflammation. However, Asian patients with CRS with NP show characteristics indicative of neutrophilic inflammation. Therefore, are eosinophils or nasal polyps more important for the classification of CRS?

Methods: A prospective cohort study conducted from April 2007 to March 2008 classified patients with CRS based on the presence of nasal polyps and mucosal eosinophilia. The recurrence rate of nasal polyps was compared between the groups. Recurrence rate was analysed as a time-dependent variable by the Kaplan-Meier method.

Results: Eosinophilic inflammation was found in 59.6% of patients with CRS with NP. Patients with mucosal eosinophilia had higher polyp recurrence rate than patients without mucosal eosinophilia, whereas patients with nasal polyps did not have higher polyp recurrence rate than patients without nasal polyps.

Conclusions: Presence of mucosal eosinophilia is a more important factor than nasal polyps for classifying CRS in terms of the surgical outcome.

Citing Articles

Inhibition of EETosis with an anti-citrullinated histone antibody: a novel therapeutic approach for eosinophilic inflammatory disorders.

Zwiers E, Montizaan D, Kip A, Waaijenberg K, Fichtinger P, Mathur S Front Immunol. 2025; 16:1533407.

PMID: 40051617 PMC: 11882434. DOI: 10.3389/fimmu.2025.1533407.


Comparison of Eosinophil Profile and Lund Kennedy Score in Patients with Nasal Polyps.

Maqsood R, Gul S, Malik J, Ali I Indian J Otolaryngol Head Neck Surg. 2024; 76(6):5542-5548.

PMID: 39559105 PMC: 11569289. DOI: 10.1007/s12070-024-05026-7.


A RESPONSE to antiIL-5 therapy in comorbid patients with chronic rhinosinusitis with nasal polyps and severe asthma: Study protocol.

Bakakos P, Alobid I, Constantinidis J, Hellings P, Pfaar O, Taille C J Allergy Clin Immunol Glob. 2024; 4(1):100343.

PMID: 39554605 PMC: 11567123. DOI: 10.1016/j.jacig.2024.100343.


Significance as a Prognostic Factor of Eosinophil Count in Nasal Polyp Tissue in Patients with Chronic Rhinosinusitis Accompanied by Asthma.

Kim M, Cho S, Lee H, Jung S, Jeong J J Clin Med. 2024; 13(19).

PMID: 39407908 PMC: 11477001. DOI: 10.3390/jcm13195849.


Functions and Clinical Applications of Extracellular Vesicles in T2 Cell-Mediated Airway Inflammatory Diseases: A Review.

Cheon J, Kim B, Lee J, Shin J, Kim T Int J Mol Sci. 2024; 25(17).

PMID: 39273399 PMC: 11394744. DOI: 10.3390/ijms25179455.